Ketamine and chronic pain - Going the distance

Pain

Volumn 145, Issue 3, 2009, Pages 271-272

  Borsook, David ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

CRPS; Disease modulation; Editorial; Ketamine; NMDA receptor

Indexed keywords

GLUTAMIC ACID; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO;

ANALGESIA; ANALGESIC ACTIVITY; BRAIN FUNCTION; CHRONIC PAIN; CLINICAL TRIAL; DEPRESSION; DRUG DOSE COMPARISON; DRUG EFFICACY; EDITORIAL; EXCITOTOXICITY; HUMAN; LOW DRUG DOSE; NERVE CELL LESION; NEUROPROTECTION; NEUROTOXICITY; PAIN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; SYNAPTIC TRANSMISSION; VISUAL ANALOG SCALE;

ANESTHETICS, DISSOCIATIVE; CHRONIC DISEASE; HUMANS; KETAMINE; PAIN;

EID: 69649092931     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2009.05.021     Document Type: Editorial

References (19)

1. Flor H., Nikolajsen L., and Staehelin Jensen T. Phantom limb pain: a case of maladaptive CNS plasticity?. Nat Rev Neurosci 7 (2006) 873-881
2. Geha P.Y., Baliki M.N., Harden R.N., Bauer W.R., Parrish T.B., and Apkarian A.V. The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions. Neuron 60 (2008) 570-581
3. Goldberg M.E., Domsky R., Scaringe D., Hirsh R., Dotson J., Sharaf I., Torjman M.C., and Schwartzman R.J. Multi-day low dose ketamine infusion for the treatment of complex regional pain syndrome. Pain Physician 8 (2005) 175-179
4. Grachev I.D., Thomas P.S., and Ramachandran T.S. Decreased levels of N-acetylaspartate in dorsolateral prefrontal cortex in a case of intractable severe sympathetically mediated chronic pain (complex regional pain syndrome, type I). Brain Cogn 49 (2002) 102-113
5. Hudetz J.A., Iqbal Z., Gandhi S.D., Patterson K.M., Byrne A.J., Hudetz A.G., Pagel P.S., and Warltier D.C. Ketamine attenuates post-operative cognitive dysfunction after cardiac surgery. Acta Anaesthesiol Scand (2009)
6. Kiefer R.T., Rohr P., Ploppa A., Dieterich H.J., Grothusen J., Koffler S., Altemeyer K.H., Unertl K., and Schwartzman R.J. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Pain Med 9 (2008) 1173-1201
7. Kiefer R.T., Rohr P., Ploppa A., Nohe B., Dieterich H.J., Grothusen J., Altemeyer K.H., Unertl K., and Schwartzman R.J. A pilot open-label study of the efficacy of subanesthetic isomeric S(+)-ketamine in refractory CRPS patients. Pain Med 9 (2008) 44-54
8. Koffler S.P., Hampstead B.M., Irani F., Tinker J., Kiefer R.T., Rohr P., and Schwartzman R.J. The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. Arch Clin Neuropsychol 22 (2007) 719-729
9. Lipton S.A. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. J Alzheimers Dis 6 (2004) S61-74
10. Machado-Vieira R, Salvadore G, Diazgranados N, Zarate Jr CA. Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther 2009, in press.
11. Maihofner C., Baron R., DeCol R., Binder A., Birklein F., Deuschl G., Handwerker H.O., and Schattschneider J. The motor system shows adaptive changes in complex regional pain syndrome. Brain 130 (2007) 2671-2687
12. McGhee LL, Maani CV, Garza TH, Gaylord KM, Black IH. The correlation between ketamine and posttraumatic stress disorder in burned service members. J Trauma 2008;64:S195-8. Discussion S197-198.
13. Millan M.J. The induction of pain: an integrative review. Prog Neurobiol 57 (1999) 1-164
14. Seifert F., Kiefer G., DeCol R., Schmelz M., and Maihofner C. Differential endogenous pain modulation in complex-regional pain syndrome. Brain 132 (2009) 788-800
15. Sigtermans M.J., van Hilten J.J., Bauer M.C.R., Sesmu Arbous M., Marinus J., Sarton E.Y., and Dahan A. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain 145 (2009) 304-311
16. Snyder G.L., Galdi S., Hendrick J.P., and Hemmings Jr. H.C. General anesthetics selectively modulate glutamatergic and dopaminergic signaling via site-specific phosphorylation in vivo. Neuropharmacology 53 (2007) 619-630
17. Verkhratsky A., and Kirchhoff F. NMDA receptors in glia. Neuroscientist 13 (2007) 28-37
18. Visser E., and Schug S.A. The role of ketamine in pain management. Biomed Pharmacother 60 (2006) 341-348
19. Winkelheide U., Lasarzik I., Kaeppel B., Winkler J., Werner C., Kochs E., and Engelhard K. Dose-dependent effect of S(+)-ketamine on post-ischemic endogenous neurogenesis in rats. Acta Anaesthesiol Scand 53 (2009) 528-533